<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="9943">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 09, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05687019</url>
  </required_header>
  <id_info>
    <org_study_id>2022-A01882-41</org_study_id>
    <nct_id>NCT05687019</nct_id>
  </id_info>
  <brief_title>Efficacy of Hyaluronic Acid Injections on Functional Recovery After Surgery for Prostate Adenoma</brief_title>
  <acronym>HOLEP-AHCS</acronym>
  <official_title>Efficacy of Hyaluronic Acid and Chondroitin Sulphate in Intravesical Injections on Functional Recovery After Holmium Laser Surgery for Prostate Adenoma (HOLEP-AHCS)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>GCS Ramsay Santé pour l'Enseignement et la Recherche</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>GCS Ramsay Santé pour l'Enseignement et la Recherche</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the score on urinary function (International&#xD;
      Prostate Score Symptom) at 28 days.&#xD;
&#xD;
      The main objective is to assess the efficacy of treatment with Ialuril® Prefill on functional&#xD;
      recovery at 4 weeks, based on the International Prostate Score Symptom.&#xD;
&#xD;
      A paired test will be performed to compare the International Prostate Score Symptom score&#xD;
      between 0 and 28 days.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is an interventional, non-comparative, open-label, monocentric study aimed at evaluating&#xD;
      treatment with hyaluronic acid in patients who have undergone surgery (HOLEP procedure) for&#xD;
      prostatic adenoma.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">January 2023</start_date>
  <completion_date type="Anticipated">February 15, 2024</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>International Prostate Score Symptom on Day 28</measure>
    <time_frame>28 days</time_frame>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">34</enrollment>
  <condition>Prostatic Adenoma</condition>
  <arm_group>
    <arm_group_label>Patient undergoing prostate enucleation by Holmium Laser</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>It is based on a pulsed laser at a wavelength of 2140 nm, which penetrates the tissues over a very short distance. The prostate tissue must therefore be in contact with the laser fiber to be cut or vaporized, and hemostasis will take place nearby. The procedure lasts approximately one hour.</description>
  </arm_group>
  <intervention>
    <intervention_type>Combination Product</intervention_type>
    <intervention_name>Intravesical instillations of Ialuril® Prefill</intervention_name>
    <description>5 injections of Ialuril® Prefill on D0 or D1, D7, D14, D21 and D28 after Holmium laser surgery for prostate adenoma</description>
    <arm_group_label>Patient undergoing prostate enucleation by Holmium Laser</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patient eligible for a HOLEP procedure, according to the investigator ;&#xD;
&#xD;
          -  Patient able to understand the information related to the clinical investigation, to&#xD;
             read the information leaflet and agrees to sign the consent form.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Known intolerance to one of the treatment components: hyaluronic acid, chondroitin&#xD;
             sulphate, calcium chloride;&#xD;
&#xD;
          -  Prostatic volume greater than 140 cm3;&#xD;
&#xD;
          -  Patient under anticoagulant treatment for secondary prevention;&#xD;
&#xD;
          -  Patient under guardianship or curatorship, or under a regime of deprivation of&#xD;
             liberty;&#xD;
&#xD;
          -  Participating patient, or in a period of exclusion from another clinical trial;&#xD;
&#xD;
          -  Patient not benefiting from a social security scheme.&#xD;
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Christophe TOLLON, MD</last_name>
    <phone>561549696</phone>
    <phone_ext>+33</phone_ext>
    <email>tol@club-internet.fr</email>
  </overall_contact>
  <verification_date>January 2023</verification_date>
  <study_first_submitted>January 6, 2023</study_first_submitted>
  <study_first_submitted_qc>January 6, 2023</study_first_submitted_qc>
  <study_first_posted type="Actual">January 17, 2023</study_first_posted>
  <last_update_submitted>January 6, 2023</last_update_submitted>
  <last_update_submitted_qc>January 6, 2023</last_update_submitted_qc>
  <last_update_posted type="Actual">January 17, 2023</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Adenoma</mesh_term>
    <mesh_term>Prostatic Hyperplasia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

